Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer

Sergio Miguel Espinoza, Harshal Indrabhan Patil, Eduardo San Martin Martinez, Rocio Casañas Pimentel, Pradum Pundlikrao Ige

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

105 Citas (Scopus)

Resumen

Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past few years. It is widely explored in drug delivery, where the development of nanomedicines for cancer, one of the major public health concerns nowadays, has not been the exception. As a biocompatible, biodegradable and bioresorbable polymer, PCL has also found plenty of uses in the form of microparticles and scaffolds; so is the main objective of the present review to emphasize its potential and present its properties along with applications in the pharmaceutical and biomedical area with a special focus on nanomedicine in cancer.

Idioma originalInglés
Páginas (desde-hasta)85-126
Número de páginas42
PublicaciónInternational Journal of Polymeric Materials and Polymeric Biomaterials
Volumen69
N.º2
DOI
EstadoPublicada - 22 ene. 2020
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer'. En conjunto forman una huella única.

Citar esto